Quick Info
Type
Tablet
Category
GENERAL
Certification
WHO-GMP | ISO 9001:2015
MOXYLON CV 625
CertifiedTABLET MOXYLON CV 625
Composition:
Amoxycillin 500mg + Clavulanic Acid 125mg
Amoxycillin 500mg + Clavulanic Acid 125mg
MOXYLON CV 625 is a broad-spectrum beta-lactamase resistant antibiotic combination tablet. The addition of Clavulanic Acid to Amoxycillin extends its spectrum of activity, making it effective against resistant organisms causing respiratory, urinary tract, skin and soft tissue infections.
- Beta-lactamase inhibitor combination for extended spectrum
- Effective against resistant bacterial strains
- Film-coated tablets for ease of swallowing
- Well-established safety and efficacy profile
- Broad-spectrum antibacterial coverage
- Treats respiratory tract infections including pneumonia and sinusitis
- Effective for urinary tract infections
- Management of skin and soft tissue infections
- Covers gram-positive and gram-negative bacteria
- Reduces treatment failure due to bacterial resistance
- Packing: 6 Tablets per strip
- Storage: Cool & dry place, below 25°C
- Shelf Life: 24 months
- Schedule: H
Disclaimer: This medicine is for professional use only. Consume only as directed by a registered medical practitioner. Keep out of reach of children.
